These drugs generated billions of dollars in revenue for drugmakers: in 2000, global revenue from AIDS remedies was $4 billion; by 2004, it jumped to $6.6 billion. In 2010, AIDS drugs cracked the $9 billion mark130 for pharmaceutical giants and topped $30 billion in 2020.
